,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Malaise,6,16417214
1,22.0,Abdominal pain,6,16417214
2,22.0,Vomiting,6,16417214
3,22.0,Nausea,6,16417214
4,22.0,Infection,6,16417214
5,22.0,Prostatic specific antigen increased,2,16417214
6,22.0,Fatigue,6,16417214
7,22.0,Diarrhoea,6,16417214
8,22.0,Constipation,6,16417214
0,22.0,Pneumonia,1,16417219
0,22.0,Somnolence,2,16417225
1,22.0,Nausea,3,16417225
2,22.0,Respiratory depression,2,16417225
3,22.0,Pancreatic carcinoma,5,16417225
0,22.0,Pharyngeal disorder,5,16417229
0,22.0,Granuloma,5,16417273
1,22.0,Disseminated Bacillus Calmette-Guerin infection,5,16417273
2,22.0,Acute respiratory failure,5,16417273
3,22.0,Disseminated intravascular coagulation,5,16417273
4,22.0,Gastritis haemorrhagic,5,16417273
5,22.0,Multiple organ dysfunction syndrome,5,16417273
6,22.0,Sepsis,5,16417273
7,22.0,Pyrexia,5,16417273
8,22.0,Hypotension,5,16417273
9,22.0,Cystitis,1,16417273
10,22.0,Urothelium erosion,5,16417273
0,22.0,Bronchitis,,16417280
1,22.0,Fistula,,16417280
2,22.0,Dyspnoea,,16417280
3,22.0,Acute respiratory failure,5,16417280
4,22.0,Papillary thyroid cancer,,16417280
0,22.0,Leukopenia,6,16417284
0,22.0,Erythema,6,16417301
1,22.0,Rash,6,16417301
2,22.0,Incorrect drug administration rate,6,16417301
3,22.0,Hypersensitivity,6,16417301
0,22.0,Death,5,16417304
0,22.0,Renal impairment,6,16417306
1,22.0,Malaise,6,16417306
2,22.0,Asthenia,6,16417306
0,22.0,Death,5,16417328
0,22.0,Death,5,16417360
0,22.1,Interstitial lung disease,5,16417363
0,22.0,Subarachnoid haemorrhage,1,16417390
1,22.0,Somnolence,1,16417390
2,22.0,Reversible cerebral vasoconstriction syndrome,1,16417390
3,22.0,Thunderclap headache,1,16417390
4,22.0,Cerebral vasoconstriction,1,16417390
5,22.0,Sensory disturbance,1,16417390
6,22.0,Dysarthria,1,16417390
7,22.0,Vision blurred,1,16417390
8,22.0,Ischaemic stroke,1,16417390
9,22.0,Speech disorder,1,16417390
10,22.0,Aphasia,1,16417390
0,22.0,Transaminases increased,2,16417409
1,22.0,Lymphopenia,1,16417409
2,22.0,Eosinophilia,1,16417409
3,22.0,Dermatitis exfoliative generalised,2,16417409
4,22.0,Drug reaction with eosinophilia and systemic symptoms,2,16417409
0,22.0,Product use in unapproved indication,6,16417431
1,22.0,Incorrect product administration duration,6,16417431
2,22.0,Throat tightness,1,16417431
3,22.0,Rash,1,16417431
0,22.0,Nausea,6,16417479
1,22.0,Diarrhoea,6,16417479
2,22.0,Decreased appetite,6,16417479
3,22.0,Peripheral arterial occlusive disease,2,16417479
4,22.0,Embolism,2,16417479
0,22.0,Influenza like illness,2,16417513
1,22.0,Cardiac arrest,2,16417513
0,22.0,Left ventricular dysfunction,1,16417526
0,22.1,Peripheral swelling,3,16417594
1,22.1,Nausea,3,16417594
2,22.1,Cerebrovascular accident,3,16417594
3,22.1,Hypoacusis,3,16417594
0,22.1,Increased appetite,6,16417596
1,22.1,Hypersomnia,6,16417596
2,22.1,Anxiety,6,16417596
3,22.1,Mental disorder,6,16417596
4,22.1,Diarrhoea,6,16417596
5,22.1,Weight increased,6,16417596
0,22.0,Malignant neoplasm progression,6,16417855
1,22.0,Metastases to lymph nodes,6,16417855
2,22.0,Invasive breast carcinoma,6,16417855
3,22.0,Metastases to bone,6,16417855
0,22.0,Chest pain,6,16417868
0,22.0,Vitamin B12 increased,6,16417869
1,22.0,Gait disturbance,6,16417869
2,22.0,Discomfort,6,16417869
3,22.0,Myalgia,2,16417869
4,22.0,Pain in extremity,2,16417869
5,22.0,Pain,2,16417869
0,22.0,Cholangitis,2,16417879
0,22.0,Thrombophlebitis,2,16417953
1,22.0,Malignant neoplasm progression,5,16417953
2,22.0,Sepsis,3,16417953
3,22.0,Febrile neutropenia,1,16417953
4,22.0,Cholangitis,3,16417953
5,22.0,Duodenal stenosis,3,16417953
0,22.0,Blood lactate dehydrogenase increased,6,16417966
1,22.0,Febrile neutropenia,1,16417966
2,22.0,Skin disorder,2,16417966
0,22.0,Blister,2,16417986
1,22.0,Pain in extremity,3,16417986
2,22.0,Decreased appetite,6,16417986
3,22.0,Abdominal pain lower,3,16417986
4,22.0,Hypersensitivity,6,16417986
5,22.0,Back pain,6,16417986
6,22.0,Product use in unapproved indication,6,16417986
7,22.0,Scar,6,16417986
8,22.0,Abdominal discomfort,6,16417986
9,22.0,Drug ineffective for unapproved indication,6,16417986
0,22.0,Renal cancer metastatic,3,16418047
0,22.0,Cataract,2,16418145
0,22.0,Ulcer,1,16418174
0,22.0,Peritonitis,6,16418194
1,22.0,Dehiscence,6,16418194
2,22.0,Disease progression,5,16418194
3,22.0,Gastrointestinal perforation,6,16418194
0,22.0,Ulcer,2,16418204
0,22.0,Portal vein embolisation,1,16418273
1,22.0,Pelvic venous thrombosis,1,16418273
2,22.0,Pulmonary embolism,1,16418273
3,22.0,Thrombosis,1,16418273
0,22.0,Hypoacusis,6,16418333
1,22.0,Off label use,6,16418333
2,22.0,Fatigue,3,16418333
3,22.0,Nasopharyngitis,6,16418333
4,22.0,Alopecia,3,16418333
0,22.0,Intestinal obstruction,6,16418356
1,22.0,Gastroenteritis,6,16418356
0,22.0,Hypoglycaemia,1,16418401
0,22.0,Purulence,2,16418425
1,22.0,Haemorrhage,2,16418425
2,22.0,Skin exfoliation,2,16418425
3,22.0,Swelling,2,16418425
4,22.0,Pain,2,16418425
0,22.0,Diarrhoea,1,16418500
1,22.0,Clostridial infection,1,16418500
0,22.0,Hypertensive crisis,1,16418511
0,22.0,Chest pain,1,16418555
1,22.0,Chest discomfort,1,16418555
2,22.0,Heart valve stenosis,1,16418555
3,22.0,Fatigue,3,16418555
4,22.0,Hot flush,3,16418555
5,22.0,Renal impairment,2,16418555
6,22.0,Pain in jaw,3,16418555
0,22.0,Pancytopenia,6,16418641
0,22.0,Facial bones fracture,1,16418653
1,22.0,Diarrhoea,1,16418653
2,22.0,Somnolence,1,16418653
0,22.0,Gastrointestinal haemorrhage,6,16418679
1,22.0,Tumour haemorrhage,6,16418679
2,22.0,Melaena,6,16418679
0,22.0,Hepatocellular injury,2,16418714
0,22.0,Angioedema,1,16418718
0,22.0,Dry mouth,6,16418745
0,22.0,Aspiration,3,16418792
1,22.0,Viral infection,3,16418792
2,22.0,Abdominal pain,3,16418792
3,22.0,Dizziness,3,16418792
4,22.0,Hypophagia,3,16418792
5,22.0,Prostatic specific antigen increased,3,16418792
6,22.0,Myalgia,3,16418792
7,22.0,Intestinal obstruction,3,16418792
8,22.0,Medication error,3,16418792
9,22.0,Product dose omission,3,16418792
10,22.0,Hypertension,3,16418792
11,22.0,Arthropathy,3,16418792
12,22.0,Asthenia,3,16418792
13,22.0,Blood potassium decreased,3,16418792
14,22.0,Cough,3,16418792
15,22.0,Vomiting,3,16418792
0,22.1,Fatigue,6,16418800
1,22.1,Blood pressure increased,6,16418800
2,22.1,Dyspnoea,3,16418800
3,22.1,Alopecia,6,16418800
4,22.1,Joint swelling,6,16418800
5,22.1,Anaemia,2,16418800
6,22.1,Bone pain,3,16418800
7,22.1,Leukopenia,2,16418800
8,22.1,General physical health deterioration,1,16418800
9,22.1,Dizziness,3,16418800
10,22.1,Concomitant disease aggravated,6,16418800
0,22.0,Leukopenia,1,16418817
1,22.0,Lymphopenia,1,16418817
2,22.0,Neutropenia,1,16418817
3,22.0,Anaemia,1,16418817
4,22.0,Peripheral arterial occlusive disease,1,16418817
0,22.0,Loss of consciousness,1,16418822
1,22.0,Hypotension,1,16418822
0,22.0,Breast cancer,6,16418830
1,22.0,Bone disorder,6,16418830
2,22.0,Inhibitory drug interaction,6,16418830
0,22.0,Pyrexia,1,16418851
1,22.0,Anaemia,1,16418851
0,22.0,Interstitial lung disease,2,16418858
1,22.0,Tumour pseudoprogression,2,16418858
2,22.0,Malignant neoplasm progression,6,16418858
0,22.0,Polycythaemia,2,16418901
0,22.0,Febrile neutropenia,1,16418904
0,22.0,Fatigue,6,16418911
1,22.0,Mucosal inflammation,6,16418911
2,22.0,Leukopenia,3,16418911
0,22.0,Metastases to central nervous system,3,16418919
0,22.0,Hyperglycaemia,1,16418944
0,22.0,Malignant neoplasm progression,6,16418992
1,22.0,Metastasis,6,16418992
0,22.0,Fall,1,16418999
0,22.0,Malignant neoplasm progression,6,16419155
1,22.0,Metastases to liver,6,16419155
0,22.0,Hepatocellular injury,1,16419164
0,22.0,Bone marrow toxicity,2,16419168
0,22.0,Sinus disorder,6,16419173
0,22.0,Gastrointestinal haemorrhage,3,16419178
1,22.0,Diarrhoea,3,16419178
2,22.0,Ulcer,3,16419178
0,22.0,Febrile neutropenia,6,16419227
0,22.0,Intentional underdose,6,16419231
0,22.0,Neutropenic sepsis,2,16419245
0,22.0,Swelling,1,16419248
1,22.0,Osteonecrosis of jaw,1,16419248
2,22.0,Exposed bone in jaw,1,16419248
3,22.0,Loose tooth,1,16419248
4,22.0,Fistula,1,16419248
5,22.0,Purulence,1,16419248
6,22.0,Periodontal disease,2,16419248
7,22.0,Gingival pain,1,16419248
8,22.0,Pain,1,16419248
0,22.0,Neuropathy peripheral,2,16419249
1,22.0,Neurotoxicity,1,16419249
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16419249
3,22.0,Nail disorder,2,16419249
0,22.0,Bone marrow toxicity,6,16419252
0,22.0,Product use in unapproved indication,6,16419283
1,22.0,Ovarian cancer recurrent,6,16419283
2,22.0,Neurotoxicity,2,16419283
3,22.0,Off label use,6,16419283
0,22.0,Performance status decreased,1,16419316
1,22.0,Colitis,1,16419316
0,22.1,Gastric cancer,6,16419358
0,22.1,C-reactive protein increased,2,16419370
1,22.1,Haemorrhage intracranial,1,16419370
2,22.1,Small intestinal perforation,1,16419370
3,22.1,Anaemia,1,16419370
0,22.0,Death,5,16419372
1,22.0,Osteonecrosis of jaw,6,16419372
0,22.0,Pelvic pain,6,16419376
1,22.0,Peripheral sensory neuropathy,6,16419376
2,22.0,Leukocytosis,6,16419376
3,22.0,Dizziness,6,16419376
4,22.0,Vertigo,6,16419376
5,22.0,Balance disorder,6,16419376
6,22.0,Hemiparesis,6,16419376
7,22.0,Disorientation,6,16419376
8,22.0,Headache,6,16419376
9,22.0,Granulocytosis,6,16419376
10,22.0,Blood creatinine increased,6,16419376
0,22.0,Proctalgia,1,16419382
0,22.0,Prostate cancer,5,16419395
0,22.0,Death,5,16419407
0,22.0,Intestinal obstruction,6,16419414
0,22.0,Metastases to bone,3,16419425
0,22.0,Drug interaction,1,16419471
1,22.0,Myoclonus,1,16419471
0,22.1,Rash pruritic,6,16419488
1,22.1,Dry skin,6,16419488
2,22.1,Drug ineffective,6,16419488
3,22.1,Intentional product use issue,6,16419488
0,22.1,Pulmonary embolism,5,16419528
0,22.0,Vertigo,1,16419539
1,22.0,Hypertension,1,16419539
2,22.0,Chills,1,16419539
3,22.0,Sinus tachycardia,1,16419539
0,22.1,Pulmonary embolism,3,16419625
0,22.0,Nausea,6,16419632
1,22.0,Fatigue,6,16419632
2,22.0,Embolism,6,16419632
3,22.0,Injection site reaction,6,16419632
4,22.0,Thrombocytopenia,6,16419632
5,22.0,Malaise,6,16419632
6,22.0,Constipation,6,16419632
7,22.0,Leukopenia,6,16419632
8,22.0,Blood bilirubin increased,6,16419632
9,22.0,Diarrhoea,6,16419632
10,22.0,Alanine aminotransferase increased,6,16419632
11,22.0,Peripheral sensory neuropathy,6,16419632
12,22.0,Oedema,6,16419632
13,22.0,Neutropenia,6,16419632
14,22.0,Aspartate aminotransferase increased,6,16419632
15,22.0,Decreased appetite,6,16419632
16,22.0,Anaemia,6,16419632
17,22.0,Vomiting,6,16419632
18,22.0,Ejection fraction decreased,6,16419632
19,22.0,Stomatitis,6,16419632
0,22.0,Transaminases increased,2,16419642
0,22.0,Platelet count decreased,3,16419646
1,22.0,Metastases to bone,3,16419646
2,22.0,Dehydration,2,16419646
3,22.0,Tumour marker increased,6,16419646
4,22.0,Bone pain,6,16419646
5,22.0,Metastases to liver,6,16419646
6,22.0,Dengue fever,6,16419646
0,22.1,Hyperthyroidism,1,16419676
1,22.1,Dysaesthesia,1,16419676
2,22.1,Alanine aminotransferase increased,1,16419676
3,22.1,Diarrhoea,3,16419676
4,22.1,Thrombocytopenia,1,16419676
5,22.1,Dysphonia,1,16419676
6,22.1,Aspartate aminotransferase increased,1,16419676
7,22.1,Diarrhoea,1,16419676
8,22.1,Dysaesthesia,1,16419676
9,22.1,Dysgeusia,1,16419676
10,22.1,Thrombocytopenia,1,16419676
11,22.1,Dysphonia,1,16419676
12,22.1,Hypocalcaemia,1,16419676
13,22.1,Hypomagnesaemia,1,16419676
14,22.1,Alanine aminotransferase increased,1,16419676
15,22.1,Alanine aminotransferase increased,1,16419676
16,22.1,Dysgeusia,1,16419676
17,22.1,Hyponatraemia,1,16419676
0,22.0,Relapsing fever,6,16419695
1,22.0,Alanine aminotransferase increased,6,16419695
2,22.0,Aspartate aminotransferase increased,6,16419695
0,22.0,Osteonecrosis of jaw,6,16419703
1,22.0,Exposed bone in jaw,6,16419703
2,22.0,Pain in jaw,6,16419703
3,22.0,Mouth ulceration,6,16419703
4,22.0,Paraesthesia oral,6,16419703
5,22.0,Mouth haemorrhage,6,16419703
0,22.0,Inflammation,6,16419705
0,22.1,Blood iron decreased,3,16419747
1,22.1,Tremor,3,16419747
2,22.1,Blood potassium decreased,1,16419747
3,22.1,Insomnia,6,16419747
4,22.1,Myalgia,3,16419747
5,22.1,Nausea,2,16419747
6,22.1,Fatigue,3,16419747
7,22.1,Platelet count decreased,6,16419747
8,22.1,Influenza,3,16419747
9,22.1,Rash,6,16419747
10,22.1,Nervousness,3,16419747
11,22.1,Vomiting,6,16419747
12,22.1,Pain,3,16419747
13,22.1,Asthenia,3,16419747
0,22.0,Death,5,16419749
0,22.0,Dyspepsia,2,16419769
1,22.0,Leukopenia,6,16419769
2,22.0,Ocular discomfort,3,16419769
3,22.0,Nausea,2,16419769
4,22.0,Decreased appetite,6,16419769
5,22.0,Eye discharge,3,16419769
6,22.0,Fatigue,6,16419769
7,22.0,Cerebrovascular accident,6,16419769
8,22.0,Feeling cold,6,16419769
9,22.0,White blood cell count decreased,6,16419769
10,22.0,Visual impairment,3,16419769
11,22.0,Ocular hyperaemia,3,16419769
12,22.0,Abdominal pain upper,6,16419769
0,22.0,Arthralgia,1,16419774
0,22.0,Death,5,16419775
0,22.0,Dyspnoea,6,16419787
1,22.0,Myalgia,6,16419787
2,22.0,Abdominal distension,3,16419787
3,22.0,Ascites,3,16419787
4,22.0,Inappropriate schedule of product administration,6,16419787
5,22.0,Hypoaesthesia,1,16419787
6,22.0,Malaise,6,16419787
7,22.0,Platelet count decreased,6,16419787
0,22.0,Chromaturia,6,16419806
1,22.0,Jaundice,6,16419806
2,22.0,Transaminases increased,6,16419806
0,22.0,Myopathy,6,16419821
1,22.0,Encephalitis,4,16419821
2,22.0,Respiratory failure,5,16419821
3,22.0,Psychotic disorder,6,16419821
4,22.0,Respiratory tract infection,5,16419821
0,22.0,Renal impairment,3,16419859
1,22.0,Dysuria,3,16419859
0,22.0,Prostate cancer,5,16419865
0,22.0,Chronic obstructive pulmonary disease,1,16419880
1,22.0,Chronic obstructive pulmonary disease,1,16419880
2,22.0,Chronic obstructive pulmonary disease,1,16419880
3,22.0,Pneumonia,2,16419880
0,22.0,Breast cancer recurrent,6,16419904
1,22.0,Transaminases increased,1,16419904
0,22.0,Death,5,16419944
0,22.0,Haemoglobin decreased,2,16419973
1,22.0,Blood potassium decreased,6,16419973
2,22.0,Fatigue,3,16419973
3,22.0,Product used for unknown indication,6,16419973
4,22.0,Loss of personal independence in daily activities,6,16419973
5,22.0,Somnolence,6,16419973
6,22.0,Nausea,2,16419973
7,22.0,Constipation,6,16419973
0,22.1,Blood albumin decreased,6,16419986
1,22.1,Dyspnoea,3,16419986
2,22.1,Blood glucose decreased,3,16419986
3,22.1,Penile swelling,6,16419986
4,22.1,Retching,1,16419986
5,22.1,Blood sodium decreased,3,16419986
6,22.1,Cardio-respiratory arrest,5,16419986
7,22.1,Functional gastrointestinal disorder,3,16419986
8,22.1,Neoplasm progression,6,16419986
9,22.1,Feeding disorder,3,16419986
10,22.1,Swelling,6,16419986
11,22.1,Oedema,6,16419986
12,22.1,Urinary retention,6,16419986
13,22.1,Pain,3,16419986
14,22.1,Vomiting,3,16419986
15,22.1,Asthenia,3,16419986
16,22.1,Fatigue,3,16419986
17,22.1,Dehydration,3,16419986
18,22.1,Feeling abnormal,3,16419986
19,22.1,Scrotal swelling,6,16419986
0,22.0,Nausea,6,16420098
1,22.0,Vomiting,6,16420098
2,22.0,Headache,6,16420098
0,22.0,Radiation pneumonitis,4,16420102
1,22.0,Lung disorder,4,16420102
0,22.0,Hepatic failure,3,16420162
0,22.0,Lung infection,3,16420168
0,22.0,Death,5,16420169
0,22.0,Insomnia,6,16420277
1,22.0,Chills,6,16420277
2,22.0,Nausea,6,16420277
3,22.0,White blood cell count decreased,6,16420277
4,22.0,Fatigue,6,16420277
5,22.0,Abdominal pain,6,16420277
6,22.0,Bone pain,6,16420277
7,22.0,Dizziness,6,16420277
8,22.0,Myalgia,6,16420277
9,22.0,Decreased appetite,6,16420277
0,22.0,Colitis microscopic,6,16420316
1,22.0,Diarrhoea,2,16420316
2,22.0,Abdominal pain,6,16420316
0,22.0,Myocardial infarction,,16420351
0,22.0,Diarrhoea,6,16420394
1,22.0,Nausea,6,16420394
2,22.0,Fatigue,6,16420394
3,22.0,Arthralgia,6,16420394
0,22.0,Vertigo,4,16420434
1,22.0,Vomiting,4,16420434
2,22.0,Fall,4,16420434
0,22.0,Deep vein thrombosis,1,16420442
0,22.0,Bicytopenia,1,16420445
0,22.0,Death,5,16420446
0,22.0,Off label use,6,16420450
1,22.0,International normalised ratio increased,2,16420450
2,22.0,Drug interaction,2,16420450
0,22.0,Nasopharyngitis,2,16420492
1,22.0,Malaise,6,16420492
2,22.0,Cough,6,16420492
3,22.0,Oropharyngeal pain,6,16420492
0,22.0,Bone marrow failure,1,16420512
0,22.0,Product administration error,2,16420591
1,22.0,Injection site abscess,2,16420591
0,22.0,Drug ineffective,5,16420603
0,22.0,Neuropathy peripheral,2,16420622
0,22.0,Neuropathy peripheral,2,16420644
0,22.0,Metastases to liver,6,16420656
1,22.0,Fatigue,6,16420656
2,22.0,Blood cholesterol increased,6,16420656
3,22.0,Feeling cold,6,16420656
4,22.0,Palpitations,6,16420656
5,22.0,Bone lesion,6,16420656
6,22.0,Haematocrit decreased,6,16420656
7,22.0,Mean cell haemoglobin decreased,6,16420656
8,22.0,White blood cell count increased,6,16420656
9,22.0,Mitral valve calcification,6,16420656
10,22.0,Aortic valve sclerosis,6,16420656
11,22.0,Metastases to central nervous system,5,16420656
12,22.0,Malignant neoplasm progression,5,16420656
13,22.0,Neuropathy peripheral,3,16420656
14,22.0,Hilar lymphadenopathy,6,16420656
15,22.0,Lymphadenopathy mediastinal,6,16420656
16,22.0,Monocyte count decreased,6,16420656
17,22.0,Blood urea decreased,6,16420656
18,22.0,Red blood cell count decreased,6,16420656
19,22.0,Lymphocyte count decreased,6,16420656
20,22.0,Red cell distribution width increased,6,16420656
21,22.0,Blood calcium increased,6,16420656
22,22.0,Mean cell volume increased,6,16420656
23,22.0,Monocyte count increased,6,16420656
24,22.0,Blood bilirubin increased,6,16420656
25,22.0,Neutrophil count increased,6,16420656
26,22.0,Impaired work ability,6,16420656
27,22.0,Oesophagitis,6,16420656
28,22.0,Constipation,6,16420656
29,22.0,Pain,6,16420656
30,22.0,Insomnia,6,16420656
31,22.0,Vitamin D decreased,6,16420656
32,22.0,Low density lipoprotein increased,6,16420656
33,22.0,Pneumonia,6,16420656
34,22.0,Metastases to meninges,6,16420656
35,22.0,Tricuspid valve incompetence,6,16420656
36,22.0,Metastases to lung,6,16420656
37,22.0,Oedema peripheral,6,16420656
38,22.0,Pollakiuria,6,16420656
39,22.0,Aphasia,6,16420656
40,22.0,Spinal pain,6,16420656
41,22.0,Alopecia,6,16420656
42,22.0,Burning sensation,6,16420656
43,22.0,Diplopia,6,16420656
44,22.0,Hepatomegaly,6,16420656
45,22.0,Blood albumin decreased,6,16420656
46,22.0,Protein total decreased,6,16420656
47,22.0,Lymphocyte count increased,6,16420656
48,22.0,Blood triglycerides increased,6,16420656
49,22.0,Non-high-density lipoprotein cholesterol increased,6,16420656
50,22.0,Carbohydrate antigen 27.29 increased,6,16420656
51,22.0,Prothrombin time prolonged,6,16420656
52,22.0,Protein urine present,6,16420656
53,22.0,Lung infiltration,6,16420656
54,22.0,Skin exfoliation,6,16420656
55,22.0,Breast cancer,5,16420656
56,22.0,General physical health deterioration,6,16420656
57,22.0,Metastases to lymph nodes,6,16420656
58,22.0,Decreased appetite,6,16420656
59,22.0,Dry skin,6,16420656
60,22.0,Haemorrhoidal haemorrhage,6,16420656
61,22.0,Crying,6,16420656
62,22.0,Stomatitis,6,16420656
63,22.0,Dizziness,6,16420656
64,22.0,Pleural effusion,6,16420656
65,22.0,Blood sodium decreased,6,16420656
66,22.0,Blood calcium decreased,6,16420656
67,22.0,Mean cell haemoglobin increased,6,16420656
68,22.0,Glycosylated haemoglobin increased,6,16420656
69,22.0,Blood alkaline phosphatase increased,6,16420656
70,22.0,Aspartate aminotransferase increased,6,16420656
71,22.0,Mean cell haemoglobin concentration increased,6,16420656
72,22.0,Mitral valve thickening,6,16420656
73,22.0,Asthenia,6,16420656
74,22.0,Radiation associated pain,1,16420656
75,22.0,Pyrexia,6,16420656
76,22.0,Transaminases increased,6,16420656
77,22.0,Blood chloride decreased,6,16420656
78,22.0,Carbohydrate antigen 15-3 increased,6,16420656
79,22.0,Blood cholesterol increased,6,16420656
80,22.0,Blood glucose increased,6,16420656
81,22.0,Aortic valve thickening,6,16420656
82,22.0,Confusional state,6,16420656
83,22.0,Metastases to bone,6,16420656
84,22.0,Taste disorder,6,16420656
85,22.0,Depression,6,16420656
86,22.0,Anhedonia,6,16420656
87,22.0,Hot flush,1,16420656
88,22.0,Dyspepsia,6,16420656
89,22.0,Cholelithiasis,6,16420656
90,22.0,Blood creatinine decreased,6,16420656
91,22.0,Urobilinogen urine increased,6,16420656
92,22.0,Hypercalcaemia,6,16420656
93,22.0,Carcinoembryonic antigen increased,6,16420656
94,22.0,Hepatic enzyme increased,6,16420656
95,22.0,Weight decreased,6,16420656
96,22.0,Lethargy,6,16420656
97,22.0,Drug intolerance,6,16420656
98,22.0,Cough,1,16420656
99,22.0,Incontinence,6,16420656
100,22.0,Alanine aminotransferase increased,6,16420656
101,22.0,Haemoglobin decreased,6,16420656
102,22.0,Platelet count increased,6,16420656
0,22.0,Pulmonary embolism,1,16420699
1,22.0,Proteinuria,6,16420699
0,22.0,Dizziness,,16420718
1,22.0,Asthenia,,16420718
2,22.0,Diarrhoea,,16420718
0,22.0,Cardiac failure,2,16420747
1,22.0,Gravitational oedema,2,16420747
2,22.0,Chest pain,2,16420747
0,22.0,Knee arthroplasty,,16420821
0,22.0,Urinary tract obstruction,3,16420829
0,22.0,Death,5,16420852
0,22.0,Pulmonary haemorrhage,5,16420906
0,22.0,Metastases to liver,6,16420910
1,22.0,Renal cancer,6,16420910
2,22.0,Metastases to lung,6,16420910
3,22.0,Malignant neoplasm progression,6,16420910
0,22.0,Gallbladder cancer,6,16420925
1,22.0,Prostatic specific antigen increased,6,16420925
0,22.0,Product dose omission,6,16420926
1,22.0,Diabetes mellitus inadequate control,1,16420926
0,22.0,Adverse drug reaction,,16420948
0,22.0,Myelodysplastic syndrome,6,16420981
1,22.0,Second primary malignancy,6,16420981
2,22.0,Hodgkin^s disease,6,16420981
0,22.0,Metapneumovirus infection,6,16420984
0,22.0,Onycholysis,6,16420989
1,22.0,Mucosal inflammation,6,16420989
2,22.0,Asthenia,6,16420989
3,22.0,Alopecia,6,16420989
4,22.0,Lacrimal disorder,6,16420989
0,22.0,Acute kidney injury,3,16420997
1,22.0,Diarrhoea,5,16420997
0,22.0,Death,5,16420998
1,22.0,Drug-induced liver injury,2,16420998
0,22.0,Sepsis,1,16421031
1,22.0,Infusion related reaction,1,16421031
0,22.1,Alanine aminotransferase increased,1,16421049
1,22.1,Aspartate aminotransferase increased,1,16421049
2,22.1,Blood chloride decreased,1,16421049
3,22.1,Blood potassium decreased,1,16421049
4,22.1,Blood sodium decreased,1,16421049
0,22.0,Infusion related reaction,2,16421051
1,22.0,Erythema,1,16421051
2,22.0,Nausea,1,16421051
0,22.0,Disease progression,,16421054
0,22.0,Scleritis,1,16421082
0,22.0,Death,5,16421096
1,22.0,Malignant neoplasm progression,6,16421096
0,22.0,Malignant neoplasm progression,5,16421107
0,22.0,Nausea,,16421113
1,22.0,Disease progression,,16421113
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16421113
0,22.0,Neutropenia,,16421138
0,22.0,Death,,16421142
0,22.0,Disease progression,,16421151
0,22.0,Wrong technique in product usage process,6,16421161
1,22.0,Diarrhoea,3,16421161
2,22.0,Death,5,16421161
3,22.0,Dehydration,1,16421161
4,22.0,Dysphagia,3,16421161
5,22.0,Onychomycosis,3,16421161
6,22.0,Skin discolouration,3,16421161
7,22.0,Nausea,3,16421161
8,22.0,Catheter site injury,6,16421161
0,22.1,Alopecia,3,16421275
1,22.1,Hair texture abnormal,3,16421275
2,22.1,Madarosis,3,16421275
3,22.1,Hair disorder,3,16421275
4,22.1,Hair colour changes,3,16421275
0,22.0,Product dose omission,6,16421277
1,22.0,Intercepted product prescribing error,6,16421277
2,22.0,Tumour marker increased,6,16421277
3,22.0,Stomatitis,3,16421277
0,22.0,Dyspnoea,,16421312
0,22.0,Pancytopenia,2,16421351
1,22.0,Acute kidney injury,2,16421351
0,22.0,Death,,16421352
0,22.0,Death,5,16421426
1,22.0,Wound haemorrhage,2,16421426
0,22.0,Diverticulitis,6,16421448
1,22.0,Diarrhoea,6,16421448
2,22.0,Abdominal pain,6,16421448
3,22.0,Nausea,6,16421448
4,22.0,Gallbladder disorder,6,16421448
5,22.0,Colitis,6,16421448
0,22.0,Infusion related reaction,2,16421482
1,22.0,Nausea,1,16421482
2,22.0,Erythema,1,16421482
0,22.0,Myoclonus,6,16421501
1,22.0,Drug interaction,6,16421501
2,22.0,Drug ineffective,6,16421501
3,22.0,Overdose,6,16421501
0,22.0,Drug ineffective,6,16421502
1,22.0,Myoclonus,1,16421502
2,22.0,Drug interaction,1,16421502
0,22.0,Anaemia,1,16421507
1,22.0,Bicytopenia,1,16421507
0,22.0,Adverse event,3,16421572
1,22.0,Product use in unapproved indication,6,16421572
2,22.0,Malignant neoplasm progression,5,16421572
3,22.0,Adverse event,6,16421572
4,22.0,Oxygen therapy,6,16421572
0,22.0,Myocarditis,5,16421659
1,22.0,Myositis,5,16421659
0,22.0,Diarrhoea,1,16421739
1,22.0,Autoimmune thyroiditis,6,16421739
2,22.0,Oesophageal candidiasis,1,16421739
3,22.0,Hypothyroidism,6,16421739
4,22.0,Diabetes mellitus,6,16421739
5,22.0,Autoimmune hepatitis,2,16421739
6,22.0,Therapeutic response decreased,6,16421739
0,22.0,Neoplasm progression,6,16421743
0,22.0,Rheumatoid arthritis,6,16421744
1,22.0,Concomitant disease aggravated,6,16421744
0,22.0,Pelvic fracture,6,16421746
1,22.0,Labelled drug-food interaction medication error,6,16421746
2,22.0,Pain,6,16421746
3,22.0,Spinal fracture,6,16421746
4,22.0,Hip fracture,6,16421746
0,22.0,Pancreatitis,1,16421748
0,22.0,Interstitial lung disease,5,16421762
0,22.0,Acute kidney injury,2,16421765
1,22.0,Pancytopenia,2,16421765
0,22.1,Adrenocorticotropic hormone deficiency,1,16421792
1,22.1,Rash,1,16421792
2,22.1,Interstitial lung disease,1,16421792
0,22.0,Urticaria,1,16421796
1,22.0,Palpitations,1,16421796
2,22.0,Hypotension,1,16421796
0,22.0,Blood urea increased,3,16421815
1,22.0,Blood creatinine increased,3,16421815
0,22.0,Intentional product use issue,6,16421832
1,22.0,Death,5,16421832
0,22.1,Malaise,6,16421858
0,22.0,Alopecia,3,16421863
1,22.0,Hair texture abnormal,6,16421863
2,22.0,Hair disorder,6,16421863
3,22.0,Hair colour changes,6,16421863
0,22.0,Drug ineffective for unapproved indication,6,16421985
0,22.0,Application site erythema,3,16421995
0,22.0,Cold sweat,1,16422241
1,22.0,Chills,1,16422241
2,22.0,Eye movement disorder,1,16422241
3,22.0,Back pain,1,16422241
4,22.0,Flushing,1,16422241
0,22.0,Blood magnesium decreased,6,16422275
1,22.0,White blood cell count decreased,6,16422275
2,22.0,Product use in unapproved indication,6,16422275
3,22.0,Haemoglobin decreased,6,16422275
4,22.0,Blood sodium decreased,6,16422275
5,22.0,Neutrophil count decreased,6,16422275
6,22.0,Dehydration,3,16422275
7,22.0,Asthenia,6,16422275
8,22.0,Chromaturia,6,16422275
0,22.0,Tumour marker increased,6,16422276
1,22.0,Breast cancer recurrent,6,16422276
2,22.0,Drug ineffective,6,16422276
0,22.0,Cardiac failure,5,16422280
1,22.0,Pericardial effusion,6,16422280
0,22.0,Nausea,2,16422307
1,22.0,Hyperglycaemia,1,16422307
2,22.0,Arthralgia,1,16422307
3,22.0,Decreased appetite,6,16422307
4,22.0,Weight decreased,2,16422307
0,22.0,Tubulointerstitial nephritis,6,16422339
1,22.0,Acute kidney injury,3,16422339
2,22.0,Chronic kidney disease,3,16422339
3,22.0,Renal injury,6,16422339
4,22.0,Dyspepsia,6,16422339
5,22.0,Renal failure,6,16422339
6,22.0,End stage renal disease,3,16422339
0,22.0,Acute myeloid leukaemia,3,16422349
0,22.0,Neurological symptom,1,16422350
1,22.0,Liver disorder,1,16422350
2,22.0,Off label use,6,16422350
3,22.0,Immune-mediated adverse reaction,1,16422350
0,22.0,Cerebrovascular accident,6,16422378
0,22.1,Cholangitis,1,16422380
0,22.0,Fatigue,6,16422384
1,22.0,Product use in unapproved indication,6,16422384
2,22.0,Alopecia,6,16422384
3,22.0,Red blood cell count decreased,6,16422384
4,22.0,Decreased appetite,2,16422384
5,22.0,Diarrhoea,2,16422384
6,22.0,Toxicity to various agents,6,16422384
7,22.0,Neuropathy peripheral,2,16422384
8,22.0,Nausea,6,16422384
9,22.0,Dizziness,6,16422384
10,22.0,Pain in extremity,6,16422384
11,22.0,Weight decreased,3,16422384
12,22.0,Pelvic pain,6,16422384
13,22.0,Hepatitis,6,16422384
14,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16422384
15,22.0,Pulmonary embolism,1,16422384
16,22.0,Vomiting,6,16422384
0,22.0,Prostatic specific antigen increased,,16422392
1,22.0,Hormone-refractory prostate cancer,,16422392
2,22.0,Metastases to liver,,16422392
0,22.0,Hormone-refractory prostate cancer,,16422393
1,22.0,Metastases to liver,,16422393
2,22.0,Prostatic specific antigen increased,,16422393
0,22.0,Neutropenia,1,16422402
1,22.0,Proteinuria,1,16422402
2,22.0,Abdominal pain,1,16422402
3,22.0,Leukopenia,1,16422402
4,22.0,Thrombocytosis,1,16422402
5,22.0,Anaemia,1,16422402
6,22.0,Escherichia urinary tract infection,1,16422402
7,22.0,Thrombocytopenia,1,16422402
8,22.0,Vomiting,1,16422402
9,22.0,Urinary tract infection bacterial,1,16422402
0,22.0,Rash maculo-papular,1,16422412
1,22.0,Rash pustular,1,16422412
2,22.0,Purpura,1,16422412
0,22.0,Death,5,16422437
0,22.0,Death,5,16422448
0,22.0,Tonsillar disorder,6,16422449
1,22.0,Lower limb fracture,6,16422449
2,22.0,Nasal disorder,6,16422449
0,22.0,Cancer pain,6,16422450
1,22.0,Neoplasm progression,6,16422450
2,22.0,Nerve root injury,6,16422450
3,22.0,Muscular weakness,6,16422450
4,22.0,Radicular pain,6,16422450
0,22.0,Gastroenteritis,1,16422476
1,22.0,Vomiting,1,16422476
2,22.0,Pneumonitis,1,16422476
0,22.0,Anaemia,1,16422481
1,22.0,Hypoalbuminaemia,1,16422481
0,22.0,Influenza,6,16422593
1,22.0,Corneal erosion,6,16422593
0,22.0,Contusion,2,16422599
1,22.0,Acute kidney injury,1,16422599
0,22.0,Psychological trauma,6,16422644
1,22.0,Alopecia,2,16422644
0,22.0,Alopecia,3,16422651
0,22.0,Alopecia,2,16422652
1,22.0,Psychological trauma,6,16422652
0,22.0,Alopecia,3,16422707
1,22.0,Psychological trauma,6,16422707
0,22.0,Umbilical haemorrhage,6,16422861
1,22.0,Hernia,6,16422861
0,22.0,Muscular weakness,6,16422862
1,22.0,Blood pressure increased,6,16422862
0,22.0,Death,5,16422863
0,22.0,Nephrolithiasis,6,16422865
1,22.0,Asthenia,6,16422865
2,22.0,Abdominal pain upper,6,16422865
3,22.0,Diarrhoea,6,16422865
4,22.0,Nausea,6,16422865
0,22.0,Malignant neoplasm progression,5,16422936
0,22.1,Intra-abdominal haemorrhage,1,16422949
1,22.1,Sepsis,1,16422949
0,22.0,Deep vein thrombosis,6,16423025
1,22.0,Therapeutic product effect incomplete,6,16423025
2,22.0,Off label use,6,16423025
0,22.0,Rash,6,16423164
1,22.0,Musculoskeletal chest pain,6,16423164
2,22.0,Stomatitis,6,16423164
3,22.0,Abdominal discomfort,6,16423164
4,22.0,Sneezing,6,16423164
5,22.0,Drug ineffective,6,16423164
6,22.0,Dyspepsia,6,16423164
0,22.0,Adverse event,6,16423185
1,22.0,Product use in unapproved indication,6,16423185
0,22.0,Localised oedema,6,16423217
1,22.0,Haematuria,1,16423217
2,22.0,Renal pain,6,16423217
3,22.0,Venous thrombosis,6,16423217
4,22.0,Device dislocation,6,16423217
5,22.0,Death,5,16423217
6,22.0,Vascular occlusion,6,16423217
7,22.0,Venous thrombosis,1,16423217
8,22.0,Arterial haemorrhage,6,16423217
0,22.0,Lung infection,1,16423267
0,22.0,Dysphagia,2,16423339
1,22.0,Atrial fibrillation,3,16423339
2,22.0,Deep vein thrombosis,6,16423339
3,22.0,Malignant neoplasm progression,5,16423339
4,22.0,Dyspnoea,3,16423339
5,22.0,Tumour lysis syndrome,5,16423339
6,22.0,Acute kidney injury,3,16423339
0,22.0,Fatigue,6,16423371
1,22.0,Dyspnoea,3,16423371
0,22.0,Vaginal haemorrhage,1,16423402
0,22.0,Osteonecrosis of jaw,1,16423411
1,22.0,Impaired healing,1,16423411
2,22.0,Exposed bone in jaw,1,16423411
3,22.0,Actinomycosis,6,16423411
0,22.0,Pain in extremity,2,16423413
1,22.0,Blood sodium decreased,6,16423413
2,22.0,Urine ketone body present,6,16423413
3,22.0,Blood potassium decreased,6,16423413
4,22.0,Peripheral swelling,2,16423413
5,22.0,Gastroenteritis,1,16423413
6,22.0,White blood cell count decreased,6,16423413
7,22.0,Dyspnoea,1,16423413
8,22.0,Haemoglobin decreased,6,16423413
9,22.0,Malignant pleural effusion,6,16423413
10,22.0,C-reactive protein increased,6,16423413
11,22.0,Mobility decreased,2,16423413
12,22.0,Platelet count decreased,6,16423413
0,22.0,Paraesthesia oral,6,16423421
1,22.0,Osteonecrosis of jaw,6,16423421
2,22.0,Pain in jaw,6,16423421
3,22.0,Mouth haemorrhage,6,16423421
4,22.0,Ear pain,6,16423421
0,22.0,Pruritus,2,16423427
1,22.0,Rash macular,2,16423427
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16423427
3,22.0,Oedema peripheral,2,16423427
4,22.0,Drug hypersensitivity,2,16423427
5,22.0,Rash maculo-papular,2,16423427
0,22.1,Mouth ulceration,1,16423430
1,22.1,Oedema,3,16423430
2,22.1,Malaise,3,16423430
3,22.1,Neuropathy peripheral,3,16423430
4,22.1,Fatigue,3,16423430
5,22.1,Pulpitis dental,1,16423430
6,22.1,Venous thrombosis limb,1,16423430
0,22.0,Ischaemic stroke,3,16423435
0,22.0,Spinal compression fracture,6,16423491
0,22.0,Intentional product use issue,6,16423492
1,22.0,Cerebral ischaemia,2,16423492
2,22.0,Off label use,6,16423492
0,22.0,Cardiac failure,3,16423522
0,22.0,Cardiac failure,2,16423535
0,22.0,Oesophagitis,6,16423603
0,22.0,Pulmonary toxicity,6,16423604
0,22.0,Bladder disorder,6,16423606
0,22.0,Pneumonitis,6,16423662
0,22.0,Renal impairment,6,16423667
1,22.0,Dysuria,6,16423667
0,22.0,Malignant neoplasm progression,2,16423688
1,22.0,Spinal cord compression,2,16423688
0,22.0,Death,5,16423689
0,22.0,Platelet count decreased,2,16423700
0,22.0,Hypomagnesaemia,6,16423717
1,22.0,Colorectal cancer,6,16423717
2,22.0,Disease progression,6,16423717
0,22.1,Thrombophlebitis,2,16423755
1,22.1,Sudden hearing loss,4,16423755
2,22.1,Cellulitis,2,16423755
0,22.0,Interstitial lung disease,2,16423762
0,22.0,Dermatitis exfoliative generalised,1,16423769
1,22.0,Aplasia,1,16423769
2,22.0,Enteritis,1,16423769
0,22.0,Brain oedema,6,16423774
0,22.0,Cystoid macular oedema,2,16423782
0,22.0,Circulatory collapse,2,16423804
1,22.0,Loss of consciousness,2,16423804
0,22.0,Off label use,6,16423812
1,22.0,Febrile neutropenia,6,16423812
2,22.0,Influenza like illness,6,16423812
0,22.0,Extravasation,2,16423814
0,22.0,Vomiting,3,16423828
1,22.0,Pulmonary embolism,1,16423828
2,22.0,Fatigue,1,16423828
3,22.0,Pain,1,16423828
4,22.0,Confusional state,1,16423828
5,22.0,Diverticulitis,1,16423828
6,22.0,Death,5,16423828
7,22.0,Fall,6,16423828
8,22.0,Pneumonia,1,16423828
9,22.0,Nausea,6,16423828
10,22.0,Atrial fibrillation,6,16423828
11,22.0,Decreased appetite,6,16423828
12,22.0,Insomnia,1,16423828
13,22.0,Influenza like illness,1,16423828
14,22.0,Pain in extremity,6,16423828
0,22.0,Neutrophil count decreased,6,16423864
1,22.0,Protein urine,6,16423864
2,22.0,Hypertension,6,16423864
3,22.0,Ascites,6,16423864
4,22.0,Diarrhoea,6,16423864
0,22.0,Cardiotoxicity,3,16423865
0,22.0,Dizziness,1,16423866
1,22.0,Tongue pruritus,1,16423866
2,22.0,Tongue disorder,1,16423866
3,22.0,Flushing,1,16423866
4,22.0,Feeling hot,1,16423866
5,22.0,Pruritus,1,16423866
6,22.0,Dyspnoea,1,16423866
7,22.0,Erythema,1,16423866
8,22.0,Dermatitis allergic,1,16423866
9,22.0,Cold sweat,1,16423866
10,22.0,Presyncope,1,16423866
0,22.0,Diarrhoea,6,16423869
1,22.0,Cardiotoxicity,6,16423869
0,22.0,Cardiotoxicity,6,16423873
1,22.0,Diarrhoea,6,16423873
0,22.0,Cardiotoxicity,6,16423874
0,22.0,Myositis,6,16423879
1,22.0,Renal impairment,6,16423879
0,22.0,Burning sensation,6,16423911
1,22.0,Muscle necrosis,4,16423911
2,22.0,Muscle atrophy,4,16423911
0,22.0,Cough,6,16423915
1,22.0,Cell marker increased,6,16423915
2,22.0,Interstitial lung disease,6,16423915
3,22.0,Productive cough,6,16423915
0,22.0,Constipation,1,16423931
1,22.0,Hydronephrosis,6,16423931
0,22.0,Somnolence,6,16423938
1,22.0,Diarrhoea,6,16423938
2,22.0,Urinary tract infection,6,16423938
3,22.0,Product dose omission,6,16423938
0,22.1,Hypomagnesaemia,3,16423970
1,22.1,Stomatitis,3,16423970
2,22.1,Nausea,3,16423970
3,22.1,Intertrigo,3,16423970
4,22.1,Rash erythematous,3,16423970
5,22.1,Leukopenia,1,16423970
6,22.1,Abdominal pain,3,16423970
7,22.1,Diarrhoea,3,16423970
8,22.1,Neutropenia,1,16423970
0,22.0,Neoplasm progression,6,16423981
1,22.0,Alopecia,1,16423981
2,22.0,Ocular hyperaemia,1,16423981
0,22.0,Bone marrow failure,6,16423993
0,22.0,Intraductal proliferative breast lesion,6,16424017
1,22.0,Adverse event,6,16424017
2,22.0,Platelet count abnormal,6,16424017
0,22.0,Hyperkalaemia,6,16424031
1,22.0,Blood creatinine increased,6,16424031
0,22.0,Neutropenia,1,16424034
1,22.0,Neuropathy peripheral,1,16424034
2,22.0,Thrombophlebitis,2,16424034
0,22.0,Blood culture positive,1,16424039
1,22.0,Vascular device infection,1,16424039
2,22.0,Urinary tract infection,1,16424039
0,22.0,Herpes zoster,2,16424041
0,22.0,Cardiotoxicity,6,16424050
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16424050
2,22.0,Neutropenia,2,16424050
0,22.1,Sinusitis,6,16424067
1,22.1,Osteonecrosis of jaw,2,16424067
2,22.1,Stomatitis,2,16424067
0,22.0,Bone marrow failure,6,16424075
0,22.0,Diarrhoea,4,16424138
1,22.0,Gastrointestinal bacterial overgrowth,6,16424138
2,22.0,Electrolyte imbalance,6,16424138
3,22.0,Coeliac disease,6,16424138
4,22.0,Acidosis,6,16424138
0,22.0,Red blood cell count decreased,6,16424206
1,22.0,Pruritus,3,16424206
2,22.0,Arthritis,6,16424206
3,22.0,Myalgia,6,16424206
4,22.0,Pain in extremity,6,16424206
5,22.0,Blood count abnormal,3,16424206
6,22.0,Neuropathy peripheral,6,16424206
7,22.0,Paraesthesia,6,16424206
8,22.0,Gait disturbance,6,16424206
9,22.0,Fatigue,6,16424206
0,22.0,Nausea,6,16424227
1,22.0,Gastric cancer,6,16424227
0,22.0,Mucosal inflammation,6,16424248
0,22.0,Skin reaction,6,16424251
1,22.0,Bone marrow failure,6,16424251
0,22.0,Bone pain,3,16424264
1,22.0,White blood cell count decreased,6,16424264
0,22.0,Hypomagnesaemia,2,16424338
1,22.0,Dermatitis acneiform,3,16424338
2,22.0,Palpitations,2,16424338
3,22.0,Stomatitis,3,16424338
0,22.0,Vomiting,6,16424355
1,22.0,Oesophagitis,2,16424355
2,22.0,Diarrhoea,6,16424355
3,22.0,Gastritis,1,16424355
4,22.0,Myalgia,6,16424355
5,22.0,Nausea,6,16424355
6,22.0,Abdominal pain,6,16424355
7,22.0,Fatigue,6,16424355
8,22.0,Pyrexia,6,16424355
0,22.1,Thrombotic microangiopathy,6,16424360
0,22.0,Splenomegaly,6,16424365
1,22.0,Bone marrow failure,6,16424365
2,22.0,Cholecystitis,6,16424365
3,22.0,Cholelithiasis,6,16424365
4,22.0,Positron emission tomogram abnormal,6,16424365
5,22.0,Neoplasm recurrence,6,16424365
6,22.0,Pulmonary fibrosis,6,16424365
7,22.0,Neurotoxicity,6,16424365
8,22.0,Hepatic cirrhosis,6,16424365
9,22.0,Gastrointestinal disorder,6,16424365
0,22.0,Loss of consciousness,1,16424385
1,22.0,Malaise,1,16424385
2,22.0,Hypotension,1,16424385
0,22.0,Febrile neutropenia,1,16424392
1,22.0,Neutropenia,6,16424392
0,22.0,Skin ulcer,,16424416
0,22.0,Irritability,,16424417
1,22.0,Chest pain,,16424417
2,22.0,Death,5,16424417
3,22.0,Neuropathy peripheral,,16424417
0,22.0,Pneumothorax,1,16424435
1,22.0,K-ras gene mutation,6,16424435
2,22.0,Dyspnoea,6,16424435
3,22.0,Pigmentation disorder,6,16424435
4,22.0,Chest pain,6,16424435
5,22.0,Pleural effusion,6,16424435
6,22.0,Mouth ulceration,6,16424435
7,22.0,Drug resistance,6,16424435
8,22.0,Skin fissures,6,16424435
9,22.0,Drug hypersensitivity,6,16424435
0,22.0,Blood pressure decreased,2,16424437
1,22.0,Off label use,3,16424437
2,22.0,Dysphonia,3,16424437
3,22.0,Internal haemorrhage,6,16424437
4,22.0,Dizziness,2,16424437
5,22.0,Overdose,,16424437
0,22.0,Intestinal metastasis,6,16424502
1,22.0,Malignant neoplasm progression,6,16424502
0,22.0,Disseminated Bacillus Calmette-Guerin infection,6,16424524
0,22.0,Diabetic hyperglycaemic coma,2,16424527
0,22.1,Mechanical ileus,6,16424531
1,22.1,Chronic kidney disease,3,16424531
2,22.1,Myocarditis,3,16424531
3,22.1,Atrial fibrillation,3,16424531
4,22.1,Cardiac failure,3,16424531
0,22.1,Dizziness,6,16424574
1,22.1,Adverse event,6,16424574
2,22.1,Platelet count decreased,2,16424574
0,22.0,Pulmonary embolism,5,16424575
0,22.0,Acute kidney injury,6,16424577
0,22.1,Hepatitis,3,16424578
1,22.1,Cholangitis,1,16424578
2,22.1,Pneumonia,3,16424578
3,22.1,Pyrexia,6,16424578
0,22.0,Death,5,16424599
0,22.0,Abdominal pain upper,1,16424628
0,22.0,Portal hypertension,3,16424644
1,22.0,Off label use,6,16424644
2,22.0,Hepatic cirrhosis,3,16424644
0,22.0,Hepatocellular injury,2,16424646
0,22.0,Nausea,1,16424652
1,22.0,Pruritus,1,16424652
2,22.0,Oxygen saturation decreased,1,16424652
3,22.0,Respiratory failure,1,16424652
0,22.0,Malignant neoplasm progression,6,16424653
1,22.0,Product use in unapproved indication,6,16424653
2,22.0,Malignant transformation,6,16424653
3,22.0,Acquired gene mutation,6,16424653
4,22.0,Drug resistance,6,16424653
5,22.0,Off label use,6,16424653
0,22.0,Product dose omission,6,16424668
1,22.0,Malaise,6,16424668
2,22.0,Pain in extremity,6,16424668
0,22.0,Malignant neoplasm progression,6,16424704
0,22.0,Anal haemorrhage,1,16424731
0,22.0,Pain,2,16424761
1,22.0,Leukopenia,6,16424761
2,22.0,Peripheral swelling,6,16424761
0,22.0,Diabetes mellitus,6,16424770
1,22.0,Blood cholesterol abnormal,6,16424770
0,22.0,Diarrhoea,1,16424772
1,22.0,Fatigue,1,16424772
2,22.0,Asthenia,1,16424772
3,22.0,Malaise,1,16424772
4,22.0,Aphthous ulcer,6,16424772
5,22.0,Mucosal inflammation,1,16424772
6,22.0,Febrile neutropenia,1,16424772
0,22.0,Arthritis,2,16424774
1,22.0,Febrile neutropenia,1,16424774
2,22.0,Urosepsis,6,16424774
0,22.0,Seizure,6,16424780
1,22.0,Cerebrovascular accident,6,16424780
0,22.0,Death,5,16424799
0,22.0,Death,5,16424802
0,22.1,Hyperhidrosis,6,16425018
1,22.1,Blood cholesterol increased,6,16425018
2,22.1,Fatigue,6,16425018
3,22.1,Somnolence,6,16425018
4,22.1,Product use in unapproved indication,6,16425018
5,22.1,Emotional disorder,6,16425018
6,22.1,Sinus congestion,6,16425018
7,22.1,Hot flush,6,16425018
8,22.1,Calculus bladder,6,16425018
9,22.1,Weight increased,6,16425018
10,22.1,Temperature intolerance,6,16425018
11,22.1,Nausea,6,16425018
0,22.0,Cerebral haemorrhage,6,16425019
0,22.0,Rectal haemorrhage,1,16425143
0,22.1,Inappropriate antidiuretic hormone secretion,1,16425187
1,22.1,Hyponatraemia,1,16425187
2,22.1,Malignant neoplasm progression,6,16425187
0,22.0,Second primary malignancy,6,16425204
1,22.0,Acute myeloid leukaemia,6,16425204
0,22.0,Product dose omission,6,16425249
1,22.0,No adverse event,6,16425249
2,22.0,Product availability issue,6,16425249
0,22.0,Death,5,16425251
0,22.0,Death,5,16425253
0,22.0,Leukaemia,6,16425256
1,22.0,Urinary tract infection,6,16425256
2,22.0,Second primary malignancy,6,16425256
0,22.0,Platelet count decreased,3,16425259
1,22.0,Decreased appetite,3,16425259
0,22.0,Metastases to meninges,3,16425263
1,22.0,Encephalopathy,3,16425263
0,22.1,Renal vein thrombosis,1,16425291
1,22.1,Neutrophil count decreased,1,16425291
2,22.1,White blood cell count decreased,1,16425291
0,22.0,Bone marrow failure,1,16425299
0,22.0,Inflammation,6,16425300
1,22.0,Arthralgia,2,16425300
2,22.0,Back pain,2,16425300
3,22.0,Intervertebral disc disorder,6,16425300
4,22.0,Pain in extremity,6,16425300
5,22.0,Hypokinesia,6,16425300
0,22.0,Polyneuropathy,6,16425320
1,22.0,Toxicity to various agents,6,16425320
2,22.0,Neuropathy peripheral,1,16425320
3,22.0,Overdose,6,16425320
4,22.0,Drug abuse,6,16425320
0,22.1,Ataxia,1,16425344
0,22.0,Acute kidney injury,3,16425369
0,22.0,Neoplasm progression,5,16425371
0,22.0,Oral candidiasis,1,16425417
1,22.0,Pneumonia,5,16425417
0,22.0,Acquired tracheo-oesophageal fistula,6,16425439
1,22.0,Pulmonary haemorrhage,5,16425439
2,22.0,Necrosis,6,16425439
0,22.0,Alopecia,3,16425478
1,22.0,Upper respiratory tract infection,6,16425478
2,22.0,Blood chromium increased,6,16425478
3,22.0,Human epidermal growth factor receptor decreased,6,16425478
4,22.0,Fatigue,3,16425478
5,22.0,Neutrophil count decreased,6,16425478
0,22.1,Sedation,6,16425479
1,22.1,Somnolence,6,16425479
2,22.1,Muscle spasms,6,16425479
3,22.1,Increased appetite,6,16425479
4,22.1,Skin exfoliation,6,16425479
5,22.1,Pain in extremity,6,16425479
6,22.1,Skin discolouration,6,16425479
7,22.1,Headache,6,16425479
8,22.1,Fatigue,6,16425479
9,22.1,Diarrhoea,6,16425479
10,22.1,Skin fissures,6,16425479
11,22.1,Weight decreased,6,16425479
0,22.0,Neoplasm progression,6,16425488
0,22.0,Death,5,16425623
0,22.0,Neutropenia,2,16425651
0,22.0,Metastases to liver,2,16425659
1,22.0,Metastases to lung,2,16425659
2,22.0,Metastases to lymph nodes,2,16425659
3,22.0,Metastases to bone,2,16425659
0,22.0,Inappropriate schedule of product administration,6,16425663
1,22.0,Death,5,16425663
0,22.0,Dry eye,6,16425704
1,22.0,Vision blurred,6,16425704
2,22.0,Pruritus,6,16425704
3,22.0,Dyspnoea,6,16425704
4,22.0,Dry mouth,6,16425704
5,22.0,Dry skin,6,16425704
0,22.1,White blood cell count decreased,6,16425710
1,22.1,Body height decreased,6,16425710
2,22.1,Product dispensing error,6,16425710
0,22.0,Heart rate increased,2,16425717
1,22.0,Thyroid hormones increased,2,16425717
2,22.0,Alopecia,6,16425717
3,22.0,Eye disorder,3,16425717
4,22.0,Dyspnoea,3,16425717
5,22.0,Stomatitis,6,16425717
0,22.0,Delirium,1,16425724
1,22.0,Fatigue,6,16425724
2,22.0,Anxiety,3,16425724
3,22.0,Insomnia,3,16425724
4,22.0,Headache,1,16425724
5,22.0,Balance disorder,6,16425724
6,22.0,Asthenia,1,16425724
0,22.0,Neoplasm progression,5,16425748
0,22.0,Peripheral swelling,6,16425766
0,22.1,Nasopharyngitis,6,16425767
1,22.1,Diarrhoea,6,16425767
0,22.0,White blood cell count decreased,2,16425771
1,22.0,Neoplasm progression,6,16425771
0,22.0,Death,5,16425777
0,22.0,Muscle spasms,3,16425784
1,22.0,Aphthous ulcer,3,16425784
2,22.0,Vision blurred,3,16425784
3,22.0,Fatigue,1,16425784
4,22.0,Oedema peripheral,3,16425784
5,22.0,Visual impairment,3,16425784
6,22.0,Fatigue,3,16425784
7,22.0,Decreased appetite,3,16425784
8,22.0,Nausea,1,16425784
9,22.0,Hypertension,3,16425784
10,22.0,Anaemia,3,16425784
11,22.0,Joint swelling,6,16425784
12,22.0,Balance disorder,3,16425784
13,22.0,Loss of personal independence in daily activities,6,16425784
14,22.0,Weight decreased,3,16425784
15,22.0,Vomiting,1,16425784
16,22.0,Diarrhoea,1,16425784
17,22.0,Dry skin,3,16425784
18,22.0,Neutropenia,3,16425784
19,22.0,Mouth ulceration,6,16425784
20,22.0,Blood magnesium abnormal,3,16425784
21,22.0,Burning sensation,3,16425784
22,22.0,Dysgeusia,3,16425784
0,22.1,Abdominal pain upper,3,16425828
1,22.1,Vomiting,1,16425828
2,22.1,Inappropriate schedule of product administration,6,16425828
3,22.1,Prostatic specific antigen increased,6,16425828
4,22.1,Off label use,6,16425828
5,22.1,Fall,6,16425828
6,22.1,Atrial fibrillation,6,16425828
7,22.1,Liver function test abnormal,1,16425828
0,22.0,Confusional state,3,16425830
0,22.0,Asthenia,6,16425831
1,22.0,Dizziness,3,16425831
2,22.0,Pain,3,16425831
3,22.0,Hospitalisation,6,16425831
4,22.0,Arthralgia,6,16425831
5,22.0,Fatigue,6,16425831
6,22.0,Chest pain,6,16425831
0,22.0,Ascites,6,16425918
1,22.0,Nausea,6,16425918
2,22.0,Vomiting,6,16425918
0,22.0,Neutropenia,6,16425934
1,22.0,Mucosal inflammation,6,16425934
2,22.0,Odynophagia,6,16425934
3,22.0,Asthenia,6,16425934
0,22.0,Osteonecrosis of jaw,6,16425935
0,22.0,Osteonecrosis of jaw,6,16425936
0,22.0,Osteonecrosis of jaw,6,16425940
0,22.0,Death,5,16425952
0,22.0,Death,5,16425957
0,22.0,Bone marrow failure,6,16425978
1,22.0,Nausea,1,16425978
2,22.0,Vomiting,1,16425978
3,22.0,Hepatic function abnormal,3,16425978
4,22.0,Vomiting,1,16425978
5,22.0,Nausea,1,16425978
0,22.0,Bone marrow failure,6,16426014
1,22.0,Diarrhoea,2,16426014
2,22.0,Interstitial lung disease,2,16426014
0,22.0,Hypothyroidism,6,16426021
1,22.0,Drug effective for unapproved indication,6,16426021
2,22.0,Product use in unapproved indication,6,16426021
3,22.0,Cervical vertebral fracture,6,16426021
0,22.0,Asthenia,6,16426025
1,22.0,Decreased appetite,6,16426025
2,22.0,Gait disturbance,6,16426025
3,22.0,Fatigue,6,16426025
4,22.0,Haematocrit decreased,2,16426025
5,22.0,Dizziness,2,16426025
6,22.0,Dehydration,1,16426025
7,22.0,Malignant neoplasm progression,6,16426025
8,22.0,Vomiting,6,16426025
9,22.0,Fall,1,16426025
10,22.0,Constipation,6,16426025
11,22.0,Nausea,3,16426025
12,22.0,Diarrhoea,3,16426025
13,22.0,Acute kidney injury,2,16426025
14,22.0,Blood pressure increased,6,16426025
15,22.0,Sensory loss,6,16426025
0,22.0,Radiation pneumonitis,2,16426026
0,22.0,Extravasation,2,16426046
0,22.0,Death,5,16426057
0,22.0,Thrombosis,6,16426113
1,22.0,Pain in extremity,3,16426113
2,22.0,Headache,3,16426113
3,22.0,Breast cancer,6,16426113
4,22.0,Gastrooesophageal reflux disease,6,16426113
5,22.0,Cardiac murmur,6,16426113
6,22.0,Generalised oedema,6,16426113
7,22.0,Constipation,3,16426113
8,22.0,Fatigue,3,16426113
9,22.0,Ovarian cancer,3,16426113
10,22.0,Pleural effusion,6,16426113
11,22.0,Dyspnoea,3,16426113
0,22.0,Acute myocardial infarction,5,16426119
0,22.0,Osteonecrosis of jaw,3,16426230
0,22.0,Diarrhoea,1,16426240
1,22.0,Pyrexia,1,16426240
2,22.0,Seizure,1,16426240
3,22.0,Nausea,1,16426240
4,22.0,Asthenia,1,16426240
0,22.0,Thrombotic stroke,3,16426241
1,22.0,Hemiparesis,3,16426241
0,22.0,Embolism,6,16426275
1,22.0,Product use in unapproved indication,6,16426275
2,22.0,Neuropathy peripheral,6,16426275
3,22.0,Neutropenic sepsis,6,16426275
4,22.0,Off label use,6,16426275
5,22.0,Ototoxicity,6,16426275
6,22.0,Renal impairment,6,16426275
0,22.0,Carbohydrate antigen 125 increased,6,16426289
1,22.0,Exposure during pregnancy,6,16426289
0,22.0,Seizure,,16426354
1,22.0,Cerebrovascular accident,,16426354
2,22.0,Metastases to central nervous system,,16426354
3,22.0,Malignant neoplasm progression,,16426354
0,22.0,Blood potassium decreased,,16426358
1,22.0,Diarrhoea,,16426358
2,22.0,Enteritis,,16426358
3,22.0,Nausea,,16426358
0,22.0,Metastatic gastric cancer,5,16426365
1,22.0,Ileus paralytic,6,16426365
2,22.0,Pain,3,16426365
3,22.0,Malignant neoplasm progression,5,16426365
4,22.0,Drug abuse,6,16426365
5,22.0,Overdose,6,16426365
6,22.0,Nausea,6,16426365
7,22.0,Abdominal pain,3,16426365
8,22.0,Hypophagia,3,16426365
9,22.0,Vomiting,3,16426365
10,22.0,Ascites,3,16426365
0,22.0,Tachypnoea,2,16426367
1,22.0,Pupillary reflex impaired,2,16426367
2,22.0,Heart rate increased,2,16426367
3,22.0,Coma,2,16426367
4,22.0,Musculoskeletal stiffness,2,16426367
0,22.0,Sepsis,,16426380
0,22.0,Loss of consciousness,1,16426413
1,22.0,Seizure,1,16426413
2,22.0,Drug interaction,1,16426413
0,22.0,Malignant neoplasm progression,6,16426517
0,22.0,Drug resistance,6,16426519
1,22.0,Reflux gastritis,3,16426519
2,22.0,Radiation pneumonitis,3,16426519
0,22.0,Breast cancer,6,16426531
1,22.0,Malignant neoplasm progression,6,16426531
2,22.0,Metastases to liver,6,16426531
0,22.0,Malignant neoplasm progression,6,16426575
0,22.0,Death,,16426585
0,22.0,Chromaturia,6,16426587
1,22.0,Transaminases increased,6,16426587
2,22.0,Jaundice,6,16426587
0,22.0,Respiratory distress,1,16426597
0,22.0,Disease progression,,16426601
0,22.0,Anaemia,1,16426604
0,22.0,Arthralgia,6,16426655
1,22.0,Blood pressure increased,3,16426655
2,22.0,Myalgia,6,16426655
3,22.0,Headache,6,16426655
0,22.0,Diarrhoea,,16426769
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16426769
0,22.0,Atypical haemolytic uraemic syndrome,2,16426773
0,22.0,Headache,1,16426782
1,22.0,Feeling cold,1,16426782
2,22.0,Chest discomfort,1,16426782
3,22.0,Chills,1,16426782
4,22.0,Respiratory distress,1,16426782
5,22.0,Tremor,1,16426782
0,22.0,Proteinuria,,16426791
0,22.0,Drug ineffective,6,16426810
1,22.0,Hyperaesthesia,2,16426810
2,22.0,Dysphagia,2,16426810
3,22.0,Paradoxical pain,2,16426810
4,22.0,Emotional distress,2,16426810
5,22.0,Agitation,2,16426810
6,22.0,Confusional state,2,16426810
7,22.0,Delirium,2,16426810
8,22.0,Somnolence,2,16426810
0,22.0,Post procedural bile leak,1,16426814
0,22.0,Ovarian cancer recurrent,6,16426833
1,22.0,Gastrooesophageal reflux disease,6,16426833
2,22.0,Malignant neoplasm progression,6,16426833
0,22.1,Anaemia,3,16426848
1,22.1,Intestinal obstruction,3,16426848
2,22.1,Hospitalisation,6,16426848
3,22.1,Constipation,6,16426848
0,22.1,Calculus bladder,6,16426861
1,22.1,Hyperhidrosis,6,16426861
2,22.1,Fatigue,6,16426861
3,22.1,Nausea,6,16426861
4,22.1,Temperature intolerance,6,16426861
5,22.1,Emotional disorder,6,16426861
6,22.1,Weight increased,6,16426861
7,22.1,Somnolence,6,16426861
8,22.1,Blood cholesterol increased,6,16426861
9,22.1,Product use in unapproved indication,6,16426861
10,22.1,Sinus congestion,6,16426861
11,22.1,Hot flush,6,16426861
0,22.0,Hypotension,2,16426874
1,22.0,Band sensation,2,16426874
0,22.0,Neuropathy peripheral,6,16426887
0,22.0,Neuropathy peripheral,1,16426913
1,22.0,Dermatitis allergic,1,16426913
0,22.0,Intestinal obstruction,6,16426937
1,22.0,Adrenal insufficiency,6,16426937
2,22.0,Malignant neoplasm progression,5,16426937
0,22.0,Disease progression,,16426968
0,22.1,Off label use,6,16427009
1,22.1,Death,5,16427009
0,22.0,Hyperbilirubinaemia,,16427163
0,22.0,Surgery,,16427231
0,22.0,Colorectal cancer metastatic,6,16427249
0,22.0,Hypophagia,2,16427272
1,22.0,Metabolic acidosis,2,16427272
2,22.0,Anaemia,2,16427272
3,22.0,Acute kidney injury,2,16427272
4,22.0,Hyperkalaemia,2,16427272
5,22.0,Nausea,2,16427272
6,22.0,Renal tubular necrosis,2,16427272
7,22.0,Vomiting,2,16427272
0,22.1,Herpes zoster,6,16427278
1,22.1,Malaise,6,16427278
2,22.1,Radiation pneumonitis,2,16427278
0,22.0,Fungal infection,3,16427284
1,22.0,Decreased appetite,3,16427284
2,22.0,Diarrhoea,3,16427284
0,22.0,Aortic aneurysm,1,16427293
1,22.0,Pyrexia,6,16427293
2,22.0,Infective aneurysm,1,16427293
3,22.0,Abdominal pain,6,16427293
0,22.0,Disease progression,,16427306
0,22.0,Osteonecrosis of jaw,6,16427347
0,22.0,Neutropenia,1,16427351
0,22.0,Cerebral infarction,6,16427359
0,22.1,Febrile bone marrow aplasia,1,16427377
0,22.0,Cerebrovascular accident,6,16427423
0,22.0,Feeling cold,3,16427442
1,22.0,Blood pressure systolic increased,2,16427442
2,22.0,Decreased activity,1,16427442
3,22.0,Diarrhoea,3,16427442
4,22.0,Protein urine present,3,16427442
5,22.0,Breath odour,3,16427442
6,22.0,Pain,3,16427442
7,22.0,Decreased appetite,3,16427442
8,22.0,Blood pressure increased,1,16427442
9,22.0,Bone pain,3,16427442
10,22.0,Influenza like illness,3,16427442
11,22.0,Pancreatitis,3,16427442
0,22.0,Metrorrhagia,1,16427511
1,22.0,Neutropenia,6,16427511
2,22.0,Interstitial lung disease,1,16427511
3,22.0,Lymphoedema,3,16427511
4,22.0,Anaemia,6,16427511
5,22.0,Inflammation,6,16427511
0,22.0,Interstitial lung disease,2,16427564
1,22.0,Hypoxia,6,16427564
2,22.0,Pneumonia,6,16427564
3,22.0,Lung cancer metastatic,6,16427564
0,22.0,Renal impairment,6,16427590
0,22.1,Apathy,6,16427634
1,22.1,Haematocrit decreased,6,16427634
2,22.1,Hypertension,3,16427634
3,22.1,Balance disorder,3,16427634
4,22.1,Muscular weakness,6,16427634
5,22.1,Hot flush,1,16427634
6,22.1,Carbohydrate antigen 125 increased,3,16427634
7,22.1,Red blood cell count decreased,6,16427634
8,22.1,Impaired quality of life,3,16427634
9,22.1,Decreased activity,3,16427634
10,22.1,Obesity,3,16427634
11,22.1,Emotional distress,6,16427634
12,22.1,Oedema peripheral,6,16427634
13,22.1,Haemoglobin decreased,6,16427634
14,22.1,Headache,6,16427634
15,22.1,Sensory loss,6,16427634
16,22.1,Paraesthesia,6,16427634
17,22.1,Dehydration,6,16427634
18,22.1,Dyspnoea,6,16427634
19,22.1,Mean cell volume increased,6,16427634
20,22.1,Contusion,6,16427634
21,22.1,Hyperhidrosis,3,16427634
22,22.1,Depression,6,16427634
23,22.1,Bipolar disorder,6,16427634
24,22.1,Blood pressure systolic increased,3,16427634
25,22.1,Anxiety,6,16427634
26,22.1,Cataract,6,16427634
27,22.1,Night sweats,2,16427634
28,22.1,Insomnia,6,16427634
29,22.1,Platelet count decreased,2,16427634
30,22.1,Fatigue,3,16427634
31,22.1,Product dose omission,6,16427634
32,22.1,Drug ineffective,6,16427634
0,22.0,Hepatic function abnormal,6,16427744
1,22.0,Bone marrow failure,6,16427744
0,22.1,Prostatic calcification,6,16427752
1,22.1,Liver disorder,2,16427752
2,22.1,Pneumonia aspiration,5,16427752
3,22.1,Pneumothorax,3,16427752
4,22.1,Liver disorder,6,16427752
5,22.1,Radiation pneumonitis,3,16427752
0,22.0,Bone marrow failure,1,16427758
1,22.0,Disease progression,6,16427758
2,22.0,Therapeutic product effect incomplete,6,16427758
3,22.0,Nausea,1,16427758
4,22.0,Liver function test abnormal,1,16427758
0,22.0,Rheumatoid arthritis,6,16427786
0,22.0,Breast cancer,5,16427787
1,22.0,Tongue discolouration,1,16427787
2,22.0,Nausea,1,16427787
0,22.1,Febrile neutropenia,3,16427826
1,22.1,Platelet count decreased,1,16427826
2,22.1,Pulmonary embolism,5,16427826
0,22.1,Pyelonephritis,6,16427843
0,22.0,Gastrointestinal disorder,2,16427856
1,22.0,Hypertension,2,16427856
2,22.0,Fatigue,2,16427856
3,22.0,Hepatic function abnormal,2,16427856
4,22.0,Cardiotoxicity,2,16427856
5,22.0,Fluid retention,2,16427856
6,22.0,Hyperglycaemia,2,16427856
7,22.0,Hypokalaemia,2,16427856
0,22.1,Psychological trauma,6,16427912
1,22.1,Alopecia,2,16427912
0,22.0,Alopecia,2,16427914
0,22.0,Alopecia,2,16427915
1,22.0,Psychological trauma,6,16427915
0,22.0,Psychological trauma,6,16427916
1,22.0,Alopecia,2,16427916
0,22.0,Alopecia,3,16427921
0,22.0,Psychological trauma,6,16427923
1,22.0,Alopecia,3,16427923
0,22.0,Alopecia,3,16427928
1,22.0,Psychological trauma,6,16427928
0,22.1,Psychological trauma,6,16427930
1,22.1,Alopecia,3,16427930
0,22.0,Impaired quality of life,6,16427937
1,22.0,Emotional distress,6,16427937
2,22.0,Anxiety,6,16427937
3,22.0,Pain,6,16427937
4,22.0,Alopecia,3,16427937
0,22.0,Hair disorder,3,16427948
1,22.0,Hair colour changes,3,16427948
2,22.0,Depression,6,16427948
3,22.0,Alopecia,3,16427948
4,22.0,Hair texture abnormal,3,16427948
5,22.0,Madarosis,3,16427948
0,22.0,Death,5,16427965
0,22.1,Emotional distress,6,16428011
1,22.1,Anxiety,6,16428011
2,22.1,Psychological trauma,6,16428011
3,22.1,Impaired quality of life,6,16428011
4,22.1,Pain,6,16428011
5,22.1,Alopecia,2,16428011
0,22.0,Malignant neoplasm progression,5,16428159
0,22.0,Dyspnoea,3,16428174
1,22.0,Pleural effusion,3,16428174
0,22.1,Anal fistula,4,16428207
0,22.0,Pneumonia,6,16428208
1,22.0,Blood sodium decreased,3,16428208
2,22.0,Seizure,6,16428208
0,22.0,Malignant neoplasm progression,5,16428219
0,22.1,Drug interaction,1,16428252
1,22.1,Stomatitis,1,16428252
0,22.1,Pneumonia cytomegaloviral,5,16428313
1,22.1,Glomerulonephritis,6,16428313
0,22.0,Malignant neoplasm progression,1,16428410
0,22.0,Metastases to chest wall,6,16428696
1,22.0,Weight decreased,6,16428696
2,22.0,Discomfort,6,16428696
3,22.0,Oedema peripheral,1,16428696
4,22.0,Decreased appetite,6,16428696
5,22.0,Fatigue,6,16428696
6,22.0,Metastases to pelvis,6,16428696
7,22.0,Oropharyngeal discomfort,6,16428696
8,22.0,Kidney enlargement,6,16428696
9,22.0,Joint swelling,6,16428696
0,22.0,Condition aggravated,2,16428701
1,22.0,Decreased appetite,2,16428701
2,22.0,Pyrexia,2,16428701
3,22.0,Weight decreased,2,16428701
4,22.0,Nausea,2,16428701
5,22.0,Hypophysitis,2,16428701
0,22.1,Intestinal obstruction,1,16428738
0,22.0,Interstitial lung disease,2,16428789
1,22.0,Chronic obstructive pulmonary disease,6,16428789
0,22.0,Tuberculosis,2,16428790
0,22.0,General physical health deterioration,6,16428852
1,22.0,Laryngeal oedema,6,16428852
2,22.0,Left atrial dilatation,6,16428852
3,22.0,Soft tissue inflammation,6,16428852
4,22.0,Arthralgia,6,16428852
5,22.0,Pneumonia,5,16428852
6,22.0,Atrioventricular block,6,16428852
7,22.0,Arteriosclerosis coronary artery,6,16428852
8,22.0,Musculoskeletal deformity,6,16428852
9,22.0,Blood glucose increased,6,16428852
10,22.0,Hypotension,5,16428852
11,22.0,Lymphatic obstruction,6,16428852
12,22.0,C-reactive protein increased,6,16428852
13,22.0,Blood creatinine increased,6,16428852
14,22.0,Left ventricular failure,5,16428852
15,22.0,Cardiogenic shock,5,16428852
16,22.0,Chest discomfort,5,16428852
17,22.0,Reflux laryngitis,6,16428852
18,22.0,Pericardial effusion,6,16428852
19,22.0,Fibrin D dimer increased,6,16428852
20,22.0,Blood gases abnormal,6,16428852
21,22.0,Acute myocardial infarction,5,16428852
22,22.0,Vomiting,5,16428852
23,22.0,Left ventricular dilatation,6,16428852
24,22.0,Hepatic steatosis,6,16428852
25,22.0,Metastases to lung,6,16428852
26,22.0,Aortic arteriosclerosis,6,16428852
27,22.0,Dyspnoea,5,16428852
28,22.0,Nausea,5,16428852
29,22.0,Tachycardia,5,16428852
30,22.0,Lymphadenopathy,6,16428852
31,22.0,Aspartate aminotransferase increased,6,16428852
0,22.1,Pleural effusion,1,16428863
0,22.0,Death,5,16428864
0,22.0,Death,5,16428896
0,22.0,Interstitial lung disease,1,16428897
1,22.0,Febrile neutropenia,1,16428897
0,22.1,Hepatic function abnormal,5,16428901
0,22.0,Acute myeloid leukaemia,3,16428967
0,22.0,Nausea,1,16428974
1,22.0,Infectious pleural effusion,1,16428974
0,22.0,Product dose omission,6,16428990
1,22.0,No adverse event,6,16428990
0,22.1,Pneumonia bacterial,5,16428991
1,22.1,Hepatitis,6,16428991
2,22.1,Lung disorder,3,16428991
3,22.1,Septic shock,6,16428991
4,22.1,Hyperuricaemia,6,16428991
5,22.1,Adrenal insufficiency,2,16428991
6,22.1,Hypoxia,6,16428991
7,22.1,Hypothyroidism,3,16428991
8,22.1,Hypertension,6,16428991
9,22.1,Pulmonary hypertension,6,16428991
10,22.1,Pneumocystis jirovecii pneumonia,6,16428991
11,22.1,Pancreatitis acute,5,16428991
12,22.1,Drug-induced liver injury,5,16428991
13,22.1,Infusion related reaction,1,16428991
0,22.0,Fatigue,1,16429016
1,22.0,Muscular weakness,1,16429016
2,22.0,Anxiety,1,16429016
3,22.0,Hot flush,1,16429016
4,22.0,Depression,1,16429016
5,22.0,Suicidal ideation,1,16429016
0,22.1,Abdominal pain upper,6,16429067
1,22.1,Dysphonia,6,16429067
2,22.1,Red blood cell count decreased,6,16429067
3,22.1,Blood iron decreased,1,16429067
4,22.1,Faeces hard,6,16429067
5,22.1,Saliva altered,6,16429067
6,22.1,Haemoglobin decreased,6,16429067
7,22.1,Blood glucose fluctuation,6,16429067
8,22.1,Peripheral swelling,6,16429067
9,22.1,Haematocrit decreased,6,16429067
10,22.1,Faeces discoloured,6,16429067
11,22.1,Blood phosphorus decreased,1,16429067
12,22.1,Diarrhoea,6,16429067
13,22.1,Abdominal distension,6,16429067
14,22.1,Protein urine present,6,16429067
15,22.1,Flatulence,6,16429067
0,22.1,Pneumonitis,2,16429100
1,22.1,Pneumonia,2,16429100
2,22.1,Sepsis,2,16429100
0,22.0,Immune-mediated adverse reaction,6,16429128
1,22.0,Ischaemia,6,16429128
2,22.0,Immune-mediated adverse reaction,1,16429128
3,22.0,Polyarthritis,1,16429128
0,22.0,Skin disorder,1,16429161
0,22.0,Chills,6,16429177
1,22.0,Nausea,1,16429177
2,22.0,Diarrhoea,1,16429177
3,22.0,Immune-mediated adverse reaction,1,16429177
4,22.0,Cold sweat,1,16429177
0,22.0,Immune-mediated adverse reaction,1,16429188
1,22.0,Polyarthritis,1,16429188
0,22.0,Gastrointestinal disorder,2,16429226
1,22.0,Blood bilirubin increased,2,16429226
0,22.0,Immune-mediated adverse reaction,1,16429280
1,22.0,Polyarthritis,1,16429280
0,22.0,Haematuria,1,16429332
1,22.0,Death,5,16429332
0,22.0,Cerebral infarction,6,16429356
1,22.0,Bedridden,6,16429356
0,22.1,Blood urine present,6,16429361
1,22.1,Nasopharyngitis,6,16429361
2,22.1,Neoplasm skin,6,16429361
3,22.1,Exposed bone in jaw,6,16429361
4,22.1,Brain neoplasm,6,16429361
0,22.0,Pulmonary embolism,6,16429374
1,22.0,Thrombosis,6,16429374
2,22.0,Fall,6,16429374
3,22.0,Femoral neck fracture,6,16429374
0,22.0,Immune-mediated enterocolitis,6,16429439
1,22.0,Product use in unapproved indication,6,16429439
2,22.0,Polyarthritis,1,16429439
3,22.0,Immune-mediated adverse reaction,1,16429439
0,22.1,Interstitial lung disease,5,16429442
0,22.0,Muscle spasms,6,16429467
1,22.0,Discomfort,6,16429467
2,22.0,Myalgia,6,16429467
0,22.0,Malignant neoplasm progression,6,16429481
0,22.0,Malaise,6,16429487
1,22.0,Pyrexia,6,16429487
2,22.0,Thyroid hormones increased,6,16429487
0,22.0,Immune-mediated adverse reaction,2,16429526
1,22.0,Product use in unapproved indication,6,16429526
2,22.0,Malignant neoplasm progression,6,16429526
3,22.0,Oligoarthritis,2,16429526
0,22.0,Death,5,16429539
1,22.0,Intentional product use issue,6,16429539
0,22.0,Hypertensive crisis,6,16429545
0,22.0,Septic shock,1,16429546
1,22.0,Pneumonia,1,16429546
2,22.0,Pleural effusion,1,16429546
3,22.0,Biliary tract infection,1,16429546
4,22.0,Pneumonia,1,16429546
0,22.0,Bile duct obstruction,5,16429571
1,22.0,Cholangitis,5,16429571
0,22.0,Pneumonia necrotising,5,16429572
1,22.0,Weight decreased,5,16429572
0,22.1,Death,5,16429576
0,22.0,Cancer pain,1,16429598
1,22.0,Metastases to skin,6,16429598
0,22.0,Intentional product use issue,6,16429615
1,22.0,Death,5,16429615
2,22.0,Off label use,6,16429615
0,22.0,Osteonecrosis of jaw,6,16429619
0,22.0,Feeling abnormal,3,16429631
1,22.0,Depression,3,16429631
2,22.0,Product use issue,6,16429631
3,22.0,Fatigue,3,16429631
4,22.0,Dehydration,3,16429631
5,22.0,Somnolence,3,16429631
6,22.0,Malaise,3,16429631
7,22.0,Intentional dose omission,6,16429631
8,22.0,Aphonia,3,16429631
9,22.0,Speech disorder,3,16429631
10,22.0,Product dose omission,6,16429631
